UltraSPECT has announced its distribution agreement with PharmaLogic for the sale of UltraSPECT’s cardiac and bone imaging applications. The agreement will enable PharmaLogic to provide its hospitals and imaging centers with access to UltraSPECT’s Xpress line of products for lower radiation dose with no diminished image quality.

Scranton Gillette Communications’ sister publications Imaging Technology News and Diagnostic and Interventional Cardiology were honored with American Society of Healthcare Publication Editors (ASHPE) 2013 awards, in recognition of editorial excellence and achievement in the field of healthcare publishing.

St. Jude Medical Inc., a global medical device company, has announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System. Patients will be implanted with the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) and Quartet lead to assess pacing in multiple locations in the heart.

eCardio Diagnostics announced the launch of eCardio Verite — a patient-friendly, wireless monitor offering seamless transition between mobile cardiac telemetry and cardiac event monitoring when directed by a physician.

 

Simbionix USA Corporation is proud to announce the release of various training modules for the ANGIO Mentor endovascular simulator.

Zoll Medical said results from the prospective registry and follow-up of Patients Using the Wearable Defibrillator (WEARIT-II) trial will be presented in a late-breaking clinical trial presentation at Heart Rhythm 2013. The session will be presented during the Heart Rhythm Society’s 34th Annual Scientific Sessions, Friday, May 10, 1:30-3 p.m., session number SP22.

InterValve Inc. announced that it has received 510(k) clearance to market the new V8 Aortic Valvuloplasty Balloon Catheter in the United States.

 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now